Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO™, the company’s bivalent Respiratory Syncytial Virus (RSV) prefusion F (RSVpreF) vaccine. This FDA approval on May 31, 2023, prevents lower respiratory... READ →
Precision Vaccinations/ June 1st, 2023
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Jun 1 • 11:40 am CDT
Jun 1 • 12:01 pm CDT
YS Biopharma Co., Ltd. today announced that its novel PIKA Rabies Vaccine was granted Phase 3 clinical trial approval from the Food and Drug Administration of the Philippines. The Phase 3 clinical trial, which is planned... READ →
May 30 • 11:54 am CDT
The U.S. CDC Morbidity and Mortality Weekly Report ( MMWR ) Podcast Briefing, published today, offers an overview of the latest scientific information regarding mpox vaccinations. This podcast discusses three MMWR reports as of the week... READ →
May 30 • 7:52 am CDT
Immorna today announced that the first subject had been dosed in the Company's First-In-Human Phase 1 multi-center study of JCXH-105, a self-replicating RNA (srRNA) vaccine being developed for the prevention of Shingles. The U.S. Food and... READ →
May 30 • 4:10 am CDT
Valneva SE today announced filing a regulatory application with Health Canada for marketing approval of the single-shot chikungunya vaccine candidate, VLA1553. If accepted by Health Canada, VLA1553 would become available for persons aged 18 years and... READ →
For more articles, try our search.